Ovarian cancer treatments reflect lack of research funding

Australia’s medical research funding systems are providing “woefully inadequate” support for ovarian cancer studies, resulting in painful treatment methods that have not changed in 30 years, a Senate inquiry has heard.

Ovarian Cancer Australia chief executive Jane Hill (above) told a public hearing in Melbourne that genomic research has “radically changed” perceptions regarding potential treatments.

“The disease is now classified into seven molecular subtypes,” she said.